Biotechnology | FDA | Oncology | Therapeutics
The FDA approved the hormone, called Epogen
On Jun. 1, 1989, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…
On Jun. 1, 1989, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…